{
  "id": "everyday#risk_safety_66f75108",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "discontinuation v. 2022;61(2):243–54 (https://doi.org/10.1016/j. maintenance of antipsychotic medication on jaac.2021.03.021). relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis. Psychol Med. 2019;49(5):772–9 (https://doi.org/10.1017/ S0033291718001393). 127 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders 201. Ciray RO, Hancer P, Tuncturk M, Emiroglu 209. mhGAP operations manual. Geneva: World NI. [Placebo-controlled pharmacological Health Organization; 2018 (https://iris.who.int/ trials in child and adolescents with bipolar handle/10665/275386). disorder manic episode (BPD-ME): systematic 210. Bighelli I, Rodolico A, García-Mieres H, Pitschel- review, meta-analysis and a meta-regression Walz G, Hansen WP, Schneider-Thoma J et al. on placebo response] (in Turkish). Turkish J Psychosocial and psychological interventions Clinical Psychiatry. 2020;23:375–85 (https://doi. for relapse prevention in schizophrenia: a org/10.5505/kpd.2020.45822). systematic review and network meta-analysis. 202. Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Lancet Psychiatry. 2021;8(11):969–80 (https://doi. Nomura I et al. Pharmacological treatment for org/10.1016/S2215-0366(21)00243-1). bipolar mania: a systematic review and network 211. Oud M, Mayo-Wilson E, Braidwood R, Schulte meta-analysis of double-blind randomized P, Jones SH, Morriss R et al. Psychological controlled trials. Mol Psychiatry. 2022;27(2):1136– interventions for adults with bipolar disorder: 44 (https://doi.org/10.1038/s41380-021-01334-4). systematic review and meta-analysis. Br J 203. Farkas R, Feeney J. Clinical review, adverse events: Psychiatry. 2016;208(3):213–22 (https://doi. carbamazepine. East Hanover (NJ): Novartis org/10.1192/bjp.bp.114.157123). Pharmaceuticals; 2007 (https://www.accessdata. 212. Stallman HM, Allen A. Acute suicide prevention: fda.gov/drugsatfda_docs/nda/2007/016608s098,0 a systematic review of the evidence and 20712s029,021710_ClinRev.pdf). implications for clinical practice. J Affect Disord 204. Meador KJ. Effects of in utero antiepileptic drug Rep. 2021;5:100148 (https://doi.org/10.1016/j. exposure. Epilepsy Curr. 2008;8(6):143–7 (https:// jadr.2021.100148). doi.org/10.1111/j.1535-7511.2008.00273.x). 213. Nuij C, Van Ballegooijen W, De Beurs D, Juniar 205. Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. D, Erlangsen A, Portzky G et al. Safety planning- Valproate for acute mania. Cochrane Database type interventions for suicide prevention: meta- Syst Rev. 2019;(10):CD004052. analysis. Br J Psychiatry. 2021;219(2):419–26 (https://doi.org/10.1192/bjp.2021.50). 206. Prescribing information: SOLTAMOX® (tamoxifen citrate) oral solution. U.S. Food and 214. House A. Safety planning-type interventions for Drug Administration; revised 2018 (https:// suicide prevention: meta-analysis. Br J Psychiatry. www.accessdata.fda.gov/drugsatfda_docs/ 2022;220(4):246 (https://doi.org/10.1192/ label/2018/021807s005lbl.pdf). bjp.2021.197). 207. Yildiz A, Siafis S, Mavridis D, Vieta E, Leucht 215. Ferguson M, Rhodes K, Loughhead M, McIntyre H, S. Comparative efficacy and tolerability of Procter N. The effectiveness of the safety planning pharmacological interventions for acute bipolar intervention for adults experiencing suicide- depression in adults: a systematic review and related distress: a systematic review. Arch Suicide network meta-analysis. Lancet Psychiatry. Res. 2022;26(3):1022–45 (https://doi.org/10.1080/1 2023;10(9):693–705 (https://doi.org/10.1016/ 3811118.2021.1915217). S2215-0366(23)00199-2). 216. Stanley B, Brown GK. Safety planning intervention: 208. Bighelli I, Salanti G, Huhn M, Schneider-Thoma a brief intervention to mitigate suicide risk. Cogn J, Krause M, Reitmeir C et al. Psychological Behav Pract. 2012;19(2):256–64 (https://doi. interventions to reduce positive symptoms in org/10.1016/j.cbpra.2011.01.001). schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018;17(3):316– 29 (https://doi.org/10.1002/wps.20577). 128",
  "gloss_vi": "Discontinuation v. 2022;61(2):243–54 (https://doi.org/10.1016/j.",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues"
    ],
    "life_topics": [
      "stress",
      "work"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "high"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn discontinuation v. 2022;61(2):243–54 (https://doi.org/10.1016/j. maintenance of antipsychotic medication on jaac.2021.03.021). relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis. Psychol Med. 2019;49(5):772–9 (https://doi.org/10.1017/ S0033291718001393). 127 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders 201. Ciray RO, Hancer P, Tuncturk M, Emiroglu 209. mhGAP operations manual. Geneva: World NI. [Placebo-controlled pharmacological Health Organization; 2018 (https://iris.who.int/ trials in child and adolescents with bipolar handle/10665/275386). disorder manic episode (BPD-ME): systematic 210. Bighelli I, Rodolico A, García-Mieres H, Pitschel- review, meta-analysis and a meta-regression Walz G, Hansen WP, Schneider-Thoma J et al. on placebo response] (in Turkish). Turkish J Psychosocial and psychological interventions Clinical Psychiatry. 2020;23:375–85 (https://doi. for relapse prevention in schizophrenia: a org/10.5505/kpd.2020.45822). systematic review and network meta-analysis. 202. Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Lancet Psychiatry. 2021;8(11):969–80 (https://doi. Nomura I et al. Pharmacological treatment for org/10.1016/S2215-0366(21)00243-1). bipolar mania: a systematic review and network 211. Oud M, Mayo-Wilson E, Braidwood R, Schulte meta-analysis of double-blind randomized P, Jones SH, Morriss R et al. Psychological controlled trials. Mol Psychiatry. 2022;27(2):1136– interventions for adults with bipolar disorder: 44 (https://doi.org/10.1038/s41380-021-01334-4). systematic review and meta-analysis. Br J 203. Farkas R, Feeney J. Clinical review, adverse events: Psychiatry. 2016;208(3):213–22 (https://doi. carbamazepine. East Hanover (NJ): Novartis org/10.1192/bjp.bp.114.157123). Pharmaceuticals; 2007 (https://www.accessdata. 212. Stallman HM, Allen A. Acute suicide prevention: fda.gov/drugsatfda_docs/nda/2007/016608s098,0 a systematic review of the evidence and 20712s029,021710_ClinRev.pdf). implications for clinical practice. J Affect Disord 204. Meador KJ. Effects of in utero antiepileptic drug Rep. 2021;5:100148 (https://doi.org/10.1016/j. exposure. Epilepsy Curr. 2008;8(6):143–7 (https:// jadr.2021.100148). doi.org/10.1111/j.1535-7511.2008.00273.x). 213. Nuij C, Van Ballegooijen W, De Beurs D, Juniar 205. Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. D, Erlangsen A, Portzky G et al. Safety planning- Valproate for acute mania. Cochrane Database type interventions for suicide prevention: meta- Syst Rev. 2019;(10):CD004052. analysis. Br J Psychiatry. 2021;219(2):419–26 (https://doi.org/10.1192/bjp.2021.50). 206. Prescribing information: SOLTAMOX® (tamoxifen citrate) oral solution. U.S. Food and 214. House A. Safety planning-type interventions for Drug Administration; revised 2018 (https:// suicide prevention: meta-analysis. Br J Psychiatry. www.accessdata.fda.gov/drugsatfda_docs/ 2022;220(4):246 (https://doi.org/10.1192/ label/2018/021807s005lbl.pdf). bjp.2021.197). 207. Yildiz A, Siafis S, Mavridis D, Vieta E, Leucht 215. Ferguson M, Rhodes K, Loughhead M, McIntyre H, S. Comparative efficacy and tolerability of Procter N. The effectiveness of the safety planning pharmacological interventions for acute bipolar intervention for adults experiencing suicide- depression in adults: a systematic review and related distress: a systematic review. Arch Suicide network meta-analysis. Lancet Psychiatry. Res. 2022;26(3):1022–45 (https://doi.org/10.1080/1 2023;10(9):693–705 (https://doi.org/10.1016/ 3811118.2021.1915217). S2215-0366(23)00199-2). 216. Stanley B, Brown GK. Safety planning intervention: 208. Bighelli I, Salanti G, Huhn M, Schneider-Thoma a brief intervention to mitigate suicide risk. Cogn J, Krause M, Reitmeir C et al. Psychological Behav Pract. 2012;19(2):256–64 (https://doi. interventions to reduce positive symptoms in org/10.1016/j.cbpra.2011.01.001). schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018;17(3):316– 29 (https://doi.org/10.1002/wps.20577). 128 Discontinuation v. 2022;61(2):243–54 (https://doi.org/10.1016/j."
}